1. Home
  2. CLDI vs AMOD Comparison

CLDI vs AMOD Comparison

Compare CLDI & AMOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDI
  • AMOD
  • Stock Information
  • Founded
  • CLDI 2014
  • AMOD 2014
  • Country
  • CLDI United States
  • AMOD United States
  • Employees
  • CLDI N/A
  • AMOD 4
  • Industry
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • AMOD
  • Sector
  • CLDI Health Care
  • AMOD
  • Exchange
  • CLDI Nasdaq
  • AMOD NYSE
  • Market Cap
  • CLDI 15.7M
  • AMOD 15.8M
  • IPO Year
  • CLDI N/A
  • AMOD N/A
  • Fundamental
  • Price
  • CLDI $0.42
  • AMOD $1.31
  • Analyst Decision
  • CLDI Strong Buy
  • AMOD
  • Analyst Count
  • CLDI 2
  • AMOD 0
  • Target Price
  • CLDI $15.00
  • AMOD N/A
  • AVG Volume (30 Days)
  • CLDI 202.2K
  • AMOD 78.9K
  • Earning Date
  • CLDI 05-13-2025
  • AMOD 05-19-2025
  • Dividend Yield
  • CLDI N/A
  • AMOD N/A
  • EPS Growth
  • CLDI N/A
  • AMOD N/A
  • EPS
  • CLDI N/A
  • AMOD 0.13
  • Revenue
  • CLDI N/A
  • AMOD N/A
  • Revenue This Year
  • CLDI N/A
  • AMOD N/A
  • Revenue Next Year
  • CLDI N/A
  • AMOD N/A
  • P/E Ratio
  • CLDI N/A
  • AMOD $10.14
  • Revenue Growth
  • CLDI N/A
  • AMOD N/A
  • 52 Week Low
  • CLDI $0.35
  • AMOD $1.02
  • 52 Week High
  • CLDI $4.90
  • AMOD $13.49
  • Technical
  • Relative Strength Index (RSI)
  • CLDI 32.77
  • AMOD N/A
  • Support Level
  • CLDI $0.46
  • AMOD N/A
  • Resistance Level
  • CLDI $0.51
  • AMOD N/A
  • Average True Range (ATR)
  • CLDI 0.05
  • AMOD 0.00
  • MACD
  • CLDI 0.01
  • AMOD 0.00
  • Stochastic Oscillator
  • CLDI 8.77
  • AMOD 0.00

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

About AMOD ALPHA MODUS HOLDINGS INC

Alpha Modus Holdings Inc is a technology company with a core focus on artificial intelligence in retail. It is engaged in creating, developing, and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision.

Share on Social Networks: